mazindol has been researched along with Pulmonary Hypertension in 2 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The use of the appetite suppressant agents aminorex and fenfluramine derivatives has been reported as a risk factor for the development of pulmonary hypertension." | 7.70 | Delayed onset of pulmonary hypertension associated with an appetite suppressant, mazindol: a case report. ( Asai, T; Hagiwara, M; Hyakkoku, M; Nishizato, K; Nozawa, Y; Shimamoto, K; Tsuchida, A; Tsuchihashi, K, 2000) |
| "The use of the appetite suppressant agents aminorex and fenfluramine derivatives has been reported as a risk factor for the development of pulmonary hypertension." | 3.70 | Delayed onset of pulmonary hypertension associated with an appetite suppressant, mazindol: a case report. ( Asai, T; Hagiwara, M; Hyakkoku, M; Nishizato, K; Nozawa, Y; Shimamoto, K; Tsuchida, A; Tsuchihashi, K, 2000) |
| "Mazindol is an imidazo-isoindole derivative, a tricyclic compound and a non-amphetamine central nervous system stimulant that blocks dopamine and norepinephrine reuptake." | 2.55 | Mazindol: a risk factor for pulmonary arterial hypertension? ( Benzouid, C; Delclaux, C; Hussey, E; Konofal, E; Lecendreux, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konofal, E | 1 |
| Benzouid, C | 1 |
| Delclaux, C | 1 |
| Lecendreux, M | 1 |
| Hussey, E | 1 |
| Hagiwara, M | 1 |
| Tsuchida, A | 1 |
| Hyakkoku, M | 1 |
| Nishizato, K | 1 |
| Asai, T | 1 |
| Nozawa, Y | 1 |
| Tsuchihashi, K | 1 |
| Shimamoto, K | 1 |
1 review available for mazindol and Pulmonary Hypertension
| Article | Year |
|---|---|
Mazindol: a risk factor for pulmonary arterial hypertension?
Topics: Central Nervous System Stimulants; Humans; Hypertension, Pulmonary; Mazindol; Risk Factors | 2017 |
1 other study available for mazindol and Pulmonary Hypertension
| Article | Year |
|---|---|
Delayed onset of pulmonary hypertension associated with an appetite suppressant, mazindol: a case report.
Topics: Adult; Aminorex; Appetite Depressants; Female; Humans; Hypertension, Pulmonary; Mazindol; Time Facto | 2000 |